Stanford School of Medicine

Clinical assistant professor Kathryne Sanserino explains why menopause can be especially intense after breast cancer treatment and how personalized, nonhormonal treatment options can help.

A Stanford Medicine-designed molecule turns BCL6, a protein that helps drive lymphoma, into a trigger for cancer-cell death.

The FDA finally gave the green light to bemotrizinol. Stanford Medicine experts share why it’s considered a massive leap forward for skin health in the U.S.

Some studies have reported that estrogen-only menopausal hormone therapy raises dementia risk. New research on Alzheimer’s disease hallmarks in autopsied brains indicates the opposite.

Peptides are everywhere online, touted for looksmaxxing, muscle building, and weight loss. Stanford Medicine experts explain what is – and isn’t – backed by evidence.

Stanford researchers have discovered that tau can interfere with the tiny powerhouses inside nerve cells, potentially triggering damage linked to Alzheimer’s and related neurodegenerative disorders.

The $20 million award supports a national network of programmable cloud laboratories that could expedite research and speed innovation.

A Stanford Medicine app found that older adults’ daily travel range shrank as temperatures rose, potentially limiting social, physical, and community activity.

A molecule that increases by a thousandfold in pythons after they eat holds promise for a weight-loss drug.

Children with multiple food allergies have several treatment options – including omalizumab and oral immunotherapy – a Stanford Medicine trial has found.